Literature DB >> 17873694

Resolution of haloperidol-induced hyperprolactinemia with aripiprazole.

Raymond A Lorenz, Benjamin Weinstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17873694     DOI： 10.1097/JCP.0b013e31814f4d5d

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  4 in total

1.  Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review.

Authors:  Konstantinos N Fountoulakis; Eduard Vieta
Journal:  Ann Gen Psychiatry       Date:  2009-07-27       Impact factor: 3.455

2.  Aripiprazole use combined with depot antipsychotic medication: two cases demonstrating its ability to reduce prolactin levels in an adolescent forensic hospital.

Authors:  Simon A Hill; Al Aditya Khan; Marion Wetherill
Journal:  Ther Adv Psychopharmacol       Date:  2011-06

Review 3.  Is Adjunct Aripiprazole Effective in Treating Hyperprolactinemia Induced by Psychotropic Medication? A Narrative Review.

Authors:  Frank M C Besag; Michael J Vasey; Iffah Salim
Journal:  CNS Drugs       Date:  2021-04-20       Impact factor: 5.749

Review 4.  Using aripiprazole to reduce antipsychotic-induced hyperprolactinemia: meta-analysis of currently available randomized controlled trials.

Authors:  Meiling Meng; Wei Li; Shaowei Zhang; Hongyan Wang; Jianhua Sheng; Jijun Wang; Chunbo Li
Journal:  Shanghai Arch Psychiatry       Date:  2015-02-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.